Research

Infectious diseases and microbiome

Search publications

Publications

  • Batlle A, Aldemira-Liz A, Agúndez B, Cabrera I, Esquerdo E, López S, Achotegui A, Villalón C and Fernández de Sevilla-Estrach M.

    Home hospitalization of the acute patient: a new approach to care.

    anales de pediatria . 99(5): 329-334.

    [doi:10.1016/j.anpede.2023.08.015]

  • Alcalá Minagorre PJ, Montiano Jorge JI and García-García JJ.

    Pediatric hospital medicine facing the new healthcare reality.

    anales de pediatria . 99(5): 293-294.

    [doi:10.1016/j.anpede.2023.10.008]

  • de Salazar A, Martínez MJ, Navero-Castillejos J, Negredo A, Galán JC, Rojo Molinero E, Lagarejos E, Munoz-Almagro C, Hernández Rodríguez Á, Lepe JA, Antón Pagarolas A, Pérez Castro S, Zamora Cintas MI, Domínguez-Gil González M, Niubó-Bosch J, Gutiérrez Arroyo A, Vazquez A, García F and Sánchez-Seco Fariñas MP.

    The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control.

    JOURNAL OF MEDICAL VIROLOGY . 95(11): .

    [doi:10.1002/jmv.29240]

  • Hernández-García M, Roldan-Berengue E, Guitart-Pardellans C, Girona M, Argüello G, Pino R, Fernández de Sevilla-Estrach M, García-García JJ and Jordán-García I.

    Multisystem inflammatory syndrome in children (MIS-C) and sepsis differentiation by a clinical and analytical score: MISSEP score.

    EUROPEAN JOURNAL OF PEDIATRICS . 182(11): 5109-5118.

    [doi:10.1007/s00431-023-05168-w]

  • Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny-Guasch C, Armangue-Salvador T, Dalmau JO, Querol L and Saiz A.

    mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis.

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 10(6): .

    [doi:10.1212/NXI.0000000000200163]

  • Hernández-García M, Claudia Solito, Pavón Ortiz A, Arguedas Casamayor N, Melé-Casas M, Pons-Tomàs G, Fernández de Sevilla-Estrach M, Pino R, Launes-Montana C, Guitart-Pardellans C, Girona M, Jordán-García I and García-García JJ.

    Characteristics and Risk Factors Associated with SARS-CoV-2 Pneumonias in Hospitalized Pediatric Patients: A Pilot Study.

    CHILDREN-BASEL . 10(10): .

    [doi:10.3390/children10101703]

  • Armangue-Salvador T, Olivé-Cirera G, Martínez-Hernandez E, Rodes M, Peris-Sempere V, Guasp M, Ruiz R, Palou E, González A, Marcos MÁ, Erro ME, Bataller L, Corral-Corral Í, Planagumà J, Caballero E, Vlagea A, Chen J, Bastard P, Materna M, Marchal A, Abel L, Cobat A, Alsina L, Fortuny-Guasch C, Saiz A, Mignot E, Vanderver A, Casanova JL, Zhang SY and Dalmau J.

    Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies.

    BRAIN . 146(10): 4306-4319. Number of citations: 2

    [doi:10.1093/brain/awad238]

  • Francisco L, Cruz-Cañete M, Pérez C, Couceiro JA, Otheo E, Launes-Montana C, Rodrigo C, Jiménez AB, Llorente M, Montesdeoca A, Rumbao J, Calvo C, Frago S and Tagarro A.

    Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP).

    anales de pediatria . 99(4): 257-263.

    [doi:10.1016/j.anpede.2023.09.006]

  • Izquierdo C, Ciruela P, Soldevila N, García-García JJ, Gonzalez-Peris S, Díaz-Conradi A, Viñado B, Fernández de Sevilla-Estrach M, Moraga-Llop F, Munoz-Almagro C, Domínguez A and Barcino Working Group.

    Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year.

    Vaccines . 11(10): .

    [doi:10.3390/vaccines11101548]

  • Shaw D, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Cao B, Casanova C, Choi EH, Chu YW, Claus H, Coelho J, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Demczuk W, Desmet S, Domenech M, Drew R, du Plessis M, Duarte C, Erlendsdóttir H, Fry NK, Fuursted K, Hale T, Henares-Bonilla D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Ip M, Jacobsson S, Johnson C, Johnston J, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, León ME, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Munoz-Almagro C, Murdoch D, Murphy J, Musilek M, Mzabi A, Novakova L, Oftadeh S, Pérez-Argüello A, Pérez-Vázquez M, Perrin M, Perry M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sheppard C, Siira L, Sintchenko V, Skoczynska A, Sloan M, Slotved HC, Smith AJ, Steens A, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Vohrnova S, von Gottberg A, Yuste J, Zanella R, Zhou F and Brueggemann AB.

    Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium.

    LANCET DIGITAL HEALTH . 5(9): .

    [doi:10.1016/S2589-7500(23)00108-5]